#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    VEXAS syndrome Retinopathy of prematurity Ovarian cancer stage IV Leiomyosarcoma Leukocyte adhesion deficiency Plasma cell myeloma Acquired ATTR amyloidosis Rectal cancer Myeloid leukaemia Acute graft versus host disease in intestine Leukaemia Extraskeletal ossification Hereditary angioedema with C1 esterase inhibitor deficiency Immune-mediated enterocolitis Deafness More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Treatment Splenic marginal zone lymphoma – Treatment Marginal zone lymphoma – Treatment Splenic marginal zone lymphoma Synovial sarcoma metastatic Epidermolysis bullosa – Diagnostics Acquired haemophilia Urea cycle disorder Rhabdoid tumour – Basic Information Paroxysmal nocturnal haemoglobinuria – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RLY-2608 Allogeneic Faecal Microbiota Pegaspargase Thalidomide Ep262 Cefotaxime Sodium MZE829 MB-CART2219.1 Lenomorelin Melatonin IHMA-2121771-1 Rocatinlimab Neratinib Clemastine Levofloxacin Bilastine Tazemetostat Blu-451 Evencaleucel SODIUM IBANDRONATE More therapies…

    Learn about Your Condition

    Aplastic anaemia Thymoma malignant Multiple system atrophy Aplasia pure red cell Noonan syndrome Melanoma recurrent Childhood asthma Coronary artery dissection Lennox-Gastaut syndrome Peritoneal dialysis Head injury Migraine Pleomorphic leiomyosarcoma Mesothelioma malignant Medulloblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Krankenhaus Nordwest GmbH

Krankenhaus Nordwest GmbH

Steinbacher Hohl 2-26, Praunheim, Frankfurt, 60488, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing BMS-986489 with Chemotherapy to Atezolizumab with Chemotherapy for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • ATIGOTATUG
    • Atezolizumab
    • Carboplatin
    Austria Belgium Czechia France Germany Greece +5

  • Study Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amivantamab
    • Cetuximab
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage IV
    • Colon cancer stage III
    Investigated Drugs:
    • Disodium Folinate
    • Calcium Folinate
    • Capecitabine
    Germany

  • Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Osimertinib
    France Germany Italy Poland Spain

  • Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanidatamab
    • Cisplatin
    • Durvalumab
    Belgium Czechia Finland France Germany Italy +4

  • Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Topotecan
    Austria Belgium Czechia France Germany Greece +7

  • Study on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • BRAF gene mutation
    Investigated Drugs:
    • (3R)-N-[3-[5-(2-Cyclopropylpyrimidin-5-Yl)-1H-Pyrrolo[2,3-B]Pyridine-3-Carbonyl]-2,4-Difluorophenyl]-3-Fluoropyrrolidine-1-Sulfonamide
    • Cobicistat
    France Germany Italy The Netherlands Norway Spain +1

  • Study on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Austria France Germany Italy Spain

  • Study on the Effectiveness of Oxaliplatin or Gemcitabine Chemotherapy in Patients with Resected Pancreatic Cancer Using Standard or Genetic Allocation Methods

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Germany Sweden

  • Study on Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin for Patients with Metastatic Colorectal Cancer After Surgery or Ablation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Disodium Folinate
    • Calcium Folinate Pentahydrate
    • Irinotecan Hydrochloride Trihydrate
    Germany
Previous Page
1 … 3 4 5 6 7 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!